Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - methotrexate, quantity: 25 mg/ml - injection, solution - excipient ingredients: sodium chloride; water for injections; sodium hydroxide - antineoplastic chemotherapy - methotrexate has a broad spectrum of antineoplastic activity. it is indicated for the treatment of breast cancer, gestational choriocarcinoma, and in patients with chorioadenoma destruens and hydatidiform mole. methotrexate may be used in combination with other chemotherapeutic agents for the palliative treatment of acute leukaemias, particularly acute lymphoblastic leukaemia. it may also be used in the treatment of burkitt's lymphoma, advanced stages (iii and iv, peters' staging system) of lymphosarcoma, especially in children, and in advanced cases of mycosis fungoides. high dose therapy - in high-dose schedules, methotrexate may be effective alone or in combination therapy, in the treatment of epidermoid cancers of the head and neck, osteogenic sarcoma and bronchogenic carcinoma. calcium folinate (leucovorin calcium) must be used in conjunction with high dose methotrexate therapy. psoriasis chemotherapy (see warning box) - methotrexate may be of value in the symptomatic control of severe, recalcitrant, disabling psoriasis which is not adequately responsive to other forms of treatment. however, due to the high risk associated with its use, methotrexate should be used after the diagnosis has been definitely established, as by biopsy and/or after dermatologic consultation.

Малта - Енглески - Medicines Authority

mylan s.a.s. 117 allee des parcs, 69800 saint priest, france - methotrexate - solution for infusion or injection - methotrexate 25 mg - antineoplastic agents

Малта - Енглески - Medicines Authority

mylan s.a.s. 117 allee des parcs, 69800 saint priest, france - methotrexate - solution for infusion or injection - methotrexate 25 mg - antineoplastic agents

Малта - Енглески - Medicines Authority

mylan s.a.s. 117 allee des parcs, 69800 saint priest, france - methotrexate - solution for infusion or injection - methotrexate 25 mg - antineoplastic agents

Малта - Енглески - Medicines Authority

mylan s.a.s. 117 allee des parcs, 69800 saint priest, france - methotrexate - solution for infusion or injection - methotrexate 25 mg/ml - antineoplastic agents

Ирска - Енглески - HPRA (Health Products Regulatory Authority)

accord healthcare limited - methotrexate - solution for injection - 50 milligram(s)/millilitre - other immunosuppressants; methotrexate

Ирска - Енглески - HPRA (Health Products Regulatory Authority)

medac gesellschaft für klinische spezialpräparate mbh - methotrexate - solution for injection in pre-filled syringe - 50 milligram(s)/millilitre - other immunosuppressants; methotrexate

Ирска - Енглески - HPRA (Health Products Regulatory Authority)

accord healthcare ireland ltd. - methotrexate - solution for injection in pre-filled syringe - 50 milligram(s)/millilitre - other immunosuppressants; methotrexate

Ирска - Енглески - HPRA (Health Products Regulatory Authority)

accord healthcare ireland ltd. - methotrexate - solution for injection in pre-filled injector - 10 milligram(s) - folic acid analogues; methotrexate

Ирска - Енглески - HPRA (Health Products Regulatory Authority)

accord healthcare ireland ltd. - methotrexate - solution for injection in pre-filled injector - 12.5 milligram(s) - folic acid analogues; methotrexate